-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Beyond the Data: Long-Term Efficacy & Safety Integrated Analyses and a Patient's Journey with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Sponsor: Apellis Pharmaceuticals
Program: Product Theaters
Hematology Disease Topics & Pathways:
Treatment Considerations, Non-Biological therapies
Saturday, December 7, 2024: 11:30 AM-12:30 PM
Room 1A (San Diego Convention Center)
Speakers:
Peter Hillmen, MB ChB, PhD, Apellis Pharmaceuticals and PNH Patient, Patient Speaker
Disclosures:
No relevant conflicts of interest to declare.

This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

This session will include a patient perspective

See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>